gastritis
Information
- Disease name
- gastritis
- Disease ID
- DOID:4029
- Description
- "A stomach disease that is an inflammation of the lining of the stomach." [url:http\://en.wikipedia.org/wiki/Gastritis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01762397 | Completed | Phase 1 | A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers | December 2012 | |
| NCT02296021 | Completed | Phase 4 | Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy | November 2014 | September 2015 |
| NCT02385045 | Completed | N/A | i-Scan for the Detection of Helicobacter Pylori | October 2014 | October 2016 |
| NCT02393430 | Completed | Phase 4 | Clinical Effect of Rebamipide on Chronic Gastritis | May 2012 | June 2014 |
| NCT02542579 | Completed | Gastric and Duodenal Microbiota in Dyspeptic Subjects | June 2016 | August 2018 | |
| NCT02597517 | Completed | New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy | November 2015 | May 2016 | |
| NCT02633930 | Completed | Phase 4 | Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy | December 2015 | August 2016 |
| NCT02724280 | Completed | N/A | Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy | September 1, 2016 | February 1, 2017 |
| NCT02884713 | Completed | N/A | Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia | June 2013 | April 2014 |
| NCT03437785 | Completed | Phase 2 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet | January 16, 2018 | October 12, 2018 |
| NCT03609892 | Completed | Phase 4 | Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy | August 1, 2018 | August 20, 2019 |
| NCT03857425 | Completed | Phase 4 | Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets | March 1, 2019 | September 15, 2019 |
| NCT03980756 | Completed | Phase 1 | A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole | June 5, 2019 | June 18, 2020 |
| NCT04255589 | Completed | Phase 3 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 | January 6, 2020 | May 20, 2021 |
| NCT04296513 | Completed | Diagnosis of Gastritis, H. Pylori Infection and Atrophic Gastritis in Dyspeptic Patients | March 1, 2020 | November 15, 2020 | |
| NCT04672018 | Completed | Phase 2 | Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis | November 8, 2022 | February 2, 2023 |
| NCT04678492 | Completed | Phase 4 | Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy | December 20, 2020 | December 20, 2021 |
| NCT04724291 | Completed | N/A | MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) | February 10, 2021 | June 10, 2023 |
| NCT05024721 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis | August 9, 2021 | March 7, 2022 |
| NCT05101395 | Completed | Prevalence of H. Pylori Gastritis in Sleeve Gastrectomy Specimens | January 1, 2015 | October 30, 2019 | |
| NCT05155072 | Completed | Phase 1 | Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903 | May 15, 2020 | September 7, 2020 |
| NCT05237115 | Completed | Phase 4 | Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy | May 5, 2020 | December 5, 2020 |
| NCT00212225 | Completed | Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) | October 1997 | December 2007 | |
| NCT00267475 | Completed | Data Bank for Eosinophilic Disorders | May 2001 | December 2012 | |
| NCT00579410 | Completed | Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule | May 2004 | October 2009 | |
| NCT00613665 | Completed | Phase 1 | Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults | February 2001 | April 2002 |
| NCT00852150 | Completed | Is a Reporting System for Gastritis or Duodenitis (Modified Lanza Scale) Reproducible? | March 2009 | December 2011 | |
| NCT00920712 | Completed | N/A | Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis | August 2009 | July 2012 |
| NCT01053871 | Completed | N/A | Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy | January 2010 | May 2010 |
| NCT01376414 | Completed | H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department | March 2011 | March 2015 | |
| NCT01576289 | Completed | Analysis of Biopsies From the Upper Gastrointestinal Tract | November 2011 | May 2012 | |
| NCT00132171 | Completed | Phase 3 | Helicobacter Pylori Eradication With a New Sequential Treatment | January 2001 | December 2001 |
| NCT01828645 | Completed | Phase 2/Phase 3 | Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein | February 2013 | March 2013 |
| NCT02165488 | Completed | Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae | June 2014 | December 2019 | |
| NCT02175186 | Completed | Phase 4 | Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention | January 21, 2015 | January 8, 2019 |
| NCT02201316 | Completed | Phase 1 | A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions | February 3, 2014 | March 18, 2014 |
| NCT02246439 | Completed | Phase 3 | BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis | December 8, 2014 | February 16, 2017 |
| NCT05510388 | Not yet recruiting | N/A | HFNO Reduces Hypoxia During Sedated Gastroscopy or Colonoscopy in High Risk Patients | September 1, 2022 | June 30, 2023 |
| NCT05742568 | Recruiting | Phase 4 | Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology | December 1, 2022 | March 10, 2024 |
| NCT05545397 | Recruiting | Sedation Level on Machine Learning With Electroencephalogram in Painless Gastroenteroscopy Patients | September 15, 2022 | December 31, 2022 | |
| NCT04306939 | Suspended | Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study | November 1, 2014 | December 1, 2025 | |
| NCT03184415 | Terminated | Phase 3 | Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis | July 3, 2017 | May 17, 2018 |
| NCT05579444 | Terminated | Systems Biology of Gastrointestinal and Related Diseases | November 11, 2022 | November 29, 2023 | |
| NCT02689583 | Unknown status | N/A | A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection | March 2016 | |
| NCT05100446 | Unknown status | Early Phase 1 | Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection | May 1, 2021 | December 31, 2022 |
| NCT02741414 | Unknown status | N/A | A Multi-center Study for Eradication of Refractory Helicobacter Pylori | June 2016 | December 2018 |
| NCT02806674 | Unknown status | N/A | A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection | July 2016 | December 2019 |
| NCT02923856 | Unknown status | N/A | A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin | January 2017 | December 2019 |
| NCT02961296 | Unknown status | Helicobacter Pylori Antibiotic Susceptibility Testing of Korea | October 2016 | December 2018 | |
| NCT03428568 | Unknown status | Phase 2 | Safety Trial of Herbal Melanin in Gastritis Patients | March 2018 | March 2020 |
| NCT03509831 | Unknown status | Phase 1 | [KJ-INT-002] BE Study | November 2, 2017 | April 2018 |
| NCT00149084 | Unknown status | Phase 3 | Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori | April 2003 | |
| NCT02353039 | Unknown status | Phase 2 | Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis | September 2014 | July 2015 |
| NCT00197418 | Unknown status | Phase 2/Phase 3 | Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection | August 2003 | |
| NCT00441831 | Unknown status | The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy | February 2007 | February 2008 | |
| NCT00487955 | Unknown status | The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure | June 2007 | December 2007 | |
| NCT05072938 | Unknown status | Phase 4 | Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis | November 2021 | December 2022 |
| NCT04289519 | Unknown status | Endoscopic Findings of Gastritis in Children | September 30, 2020 | April 30, 2021 |
- Disase is a (Disease Ontology)
- DOID:76
- Cross Reference ID (Disease Ontology)
- ICD10CM:K29.7
- Cross Reference ID (Disease Ontology)
- MESH:D005756
- Cross Reference ID (Disease Ontology)
- NCI:C26780
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155711008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0017152
- Exact Synonym (Disease Ontology)
- acute gastric mucosal erosion
- Exact Synonym (Disease Ontology)
- Erosive Gastritis
- Exact Synonym (Disease Ontology)
- Erosive gastropathy
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0005263
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005756